Literature DB >> 11316868

Left ventricular hypertrophy in the renal patient.

Rachel J Middleton1, Patrick S Parfrey2, Robert N Foley1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11316868     DOI： 10.1681/ASN.V1251079

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  73 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

2.  Concomitant coronary and renal revascularization improves left ventricular hypertrophy more than coronary stenting alone in patients with ischemic heart and renal disease.

Authors:  Hao-jian Dong; Cheng Huang; De-mou Luo; Jing-guang Ye; Jun-qing Yang; Guang Li; Jian-fang Luo; Ying-ling Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

Review 3.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 4.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

Review 5.  Evidence-based cardiology in hemodialysis patients.

Authors:  Michael Allon
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

Review 6.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

Review 7.  Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.

Authors:  John M Hamlyn; Paolo Manunta
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

8.  Coexisting cardiac diseases and pressure recovery phenomenon contribute to discrepancy between the echocardiographic severity of aortic stenosis and left ventricular hypertrophy.

Authors:  Ayumu Abe; Taisei Mikami; Sanae Kaga; Kanako Tsuji; Kazunori Okada; Shinobu Yokoyama; Hisao Nishino; Masahiro Nakabachi; Mutsumi Nishida; Chikara Shimizu; Hiroyuki Iwano; Satoshi Yamada; Hiroyuki Tsutsui
Journal:  J Echocardiogr       Date:  2013-01-09

9.  Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation.

Authors:  Waqas Aftab; Juliana Gazallo; Ali Motabar; Padmini Varadrajan; Prakash C Deedwania; Ramdas G Pai
Journal:  Int J Angiol       Date:  2015-06

Review 10.  Epidemiology and importance of renal dysfunction in heart failure patients.

Authors:  Gregory Giamouzis; Andreas P Kalogeropoulos; Javed Butler; Georgios Karayannis; Vasiliki V Georgiopoulou; John Skoularigis; Filippos Triposkiadis
Journal:  Curr Heart Fail Rep       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.